Role of Macrophage-derived Histamine in Atherosclerosis<BR>— Chronic Participation in the Inflammatory Response —
Tóm tắt
Từ khóa
Tài liệu tham khảo
(1) Ishizaka T and Conrad DH: Binding characteristics of human IgE receptors and initial triggering events in human mast cells for histamine release. Monogr Allergy, 18: 14−24, 1983
(2) Falus A and Meterey K: Histamine: an early messenger in inflammatory and immune reactions. Immunol Today, 13: 154−156, 1990
(3) Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ 2nd, and Virmani R: Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med, 313: 1138−1141, 1985
(4) Laine P, Kaartinen M, Penttila A, Panula P, Paavonen T, and Kovanen PT: Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation, 99: 361−369, 1999
(5) Kaartinen M, van der Wal AC, van der Loos CM, Piek JJ, Koch KT, Becker AE, and Kovanen PT: Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Coll Cardiol, 32: 606−612, 1998
(6) Gupta MK, Gupta P, and Rezai F: Histamine − Can it cause an acute coronary event? Clin Cardiol, 24: 258−259, 2001
(7) Clejan S, Japa S, Clemetson C, Hasabnis SS, David O, and Talano JV: Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis. J Cell Mol Med, 6: 583−592, 2002
(8) Higuchi S, Tanimoto A, Arima N, Xu H, Murata Y, Hamada T, Makishima K, and Sasaguri Y: Effects of histamine and interleukin-4 synthesized in arterial intima on phagocytosis by monocytes/macrophages in relation to atherosclerosis. FEBS Lett, 505: 217−222, 2001
(9) Wang KY, Arima N, Higuchi S, Shimajiri S, Tanimoto A, Murata Y, Hamada T, and Sasaguri Y: Switch of histamine receptor expression from H2 to H1 during differentiation of monocytes into macrophages. FEBS Lett, 473: 345−348, 2000
(10) Tanimoto A, Murata Y, Nomaguchi M, Kimura S, Arima N, Xu H, Hamada T, and Sasaguri Y: Histamine increases the expression of LOX-1 via H2 receptor in human monocytic THP-1 cells. FEBS Lett, 508: 345−349, 2001
(11) Mirossay L, Chastre E, Callebert J, Launay LM, Housset B, Zimber A, Abita JP, and Gespach C: Histamine H2 receptors and histidine decarboxylase in normal and leukemic human monocytes and macrophages. Am J Physiol, 267 (2 Pt 2): R602−R611, 1994
(12) Zwadlo-Klarwasser G, Vogts M, Hamann W, Belke K, Baron J, and Schmutzler W: Generation and subcellular distribution of histamine in human blood monocytes and monocyte subsets. Inflamm Res, 47: 434−439, 1998
(13) Yatsunami K, Ohtsu H, Tsuchikawa M, Higuchi T, Ishibashi K, Shida A, Shima Y, Nakagawa S, Yamauchi K, Yamamoto M, Hayashi N, Watanabe T, and Ichikawa A: Structure of the L-histidine decarboxylase gene. J Biol Chem, 269: 1554−1559, 1994
(14) Zhang Z, Hocker M, Koh TJ, and Wang TC: The human histidine decarboxylase promoter is regulated by gastrin and phorbol 12-myristate 13-acetate through a downstream cis-acting element. J Biol Chem, 271: 14188−14197, 1996
(15) Tanaka S, Nemoto K, Yamamura E, and Ichikawa A: Intracellular localization of the 74- and 53-kDa forms of L-histidine decarboxylase in a rat basophil/mast cell line, RBL-2H3. J Biol Chem, 273: 8177−8182, 1998
(16) Kubota H, Taguchi Y, Tohyama M, Matsuura N, Shiosaka S, Ishihara T, Watanabe T, Shiotani Y, and Wada H: Electron microscopic identification of histidine decarboxylase-containing endocrine cells of the rat gastric mucosa. An immunohistochemical analysis.Gastroenterology, 87: 496−502, 1984
(17) Taguchi Y, Tsuyama K, Watanabe T, Wada H, and Kitamura Y: Increase in histidine decarboxylase activity in skin of genetically mast-cell-deficient W/W mice after application of phorbol 12-myristate 13-acetate: evidence for the presence of histamine-producing cells without basophilic granules. Proc Natl Acad Sci U S A, 79: 6937−6841, 1982
(18) Safina F, Tanaka S, Inagaki M, Tsuboi K, Sugimoto Y, and Ichikawa A: Expression of L-histidine decarboxylase in mouse male germ cells. J Biol Chem, 277: 14211−14215, 2002
(19) Matsuki Y, Tanimoto A, Hamada T, and Sasaguri Y: Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma. Mod Pathol, 16: 72−78, 2003
(20) Laszlo V, Rothe G, Hegyesi H, Szeberenyi JB, Orso E, Schmitz G, and Falus A: Increased histidine decarboxylase expression during in vitro monocyte maturation; a possible role of endogenously synthesized histamine in monocytes/macrophage differentiation. Inflamm Res, 50: 428−434, 2001
(21) Hocker M, Henihan RJ, Rosewicz S, Riecken EO, Zhang Z, Koh TJ, and Wang TC: Gastrin and phorbol 12-myristate 13-acetate regulate the human histidine decarboxylase promoter through raf-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer cells. J Biol Chem, 272: 27015−27024, 1997
(22) Rayshowdhury R, Zhang Z, Hocker M, and Wang TC: Activation of human histidine decarboxylase gene promoter activity by gastrin is mediated by two distinct nuclear factors. J Biol Chem, 274: 20961−20969, 1999
(23) Fukui H, Fujimoto K, Mizuguchi H, Sakamoto K, Horio Y, Takai S, Yamada K, and Ito S: Molecular cloning of the human histamine H1 receptor gene. Biochem Biophys Res Commun, 201: 894−901, 1994
(24) Grantz I, Schaffer M, DelValle J, Logsdon C, Campbell V, Uhler M, and Yamada T: Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci U S A, 88: 429−433, 1991
(25) Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, and Erlander MG: Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol, 55: 1101−1107, 1999
(26) Oda T, Morikawa N, Saito Y, Masuho Y, and Matsumoto S: Molecular cloning and characterization of novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem, 275: 36781−36786, 2000
(27) Rocklin RE: Histamine-induced suppressor factor (HSF): effect on migration inhibitory factor (MIF) production and proliferation. J Immunol, 118: 1734−1738, 1977
(28) Ogden BE and Hill RE: Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors. Immunology, 41: 107−114, 1980
(29) Beer DJS, Matoloff SM, and Rocklin RE: The influence of histamine on immune and inflammatory responses. Adv Immunol 35: 209−268, 1984
(30) Shiraishi M, Hirasawa N, Kobayashi Y, Oikawa S, Murakami A, and Ohuchi K: Participation of mitogen-activated protein kinase in thapsigargin- and TPA-induced histamine production in murine macrophage RAW 264.7 cells. Br J Pharmacol, 129: 515−524, 2000
(31) Ghosh AK, Hirasawa N, Ohtsu H, Watanabe T, and Ohuchi K: Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med, 195: 973−982, 2002
(32) Takagishi T, Sasaguri Y, Nakano R, Arima N, Tanimoto A, Fukui H, and Morimatsu M: Expression of the histamine H1 receptor gene in relation to atherosclerosis. Am J Pathol, 146: 981−988, 1995
(33) Murahashi N, Sasaguri Y, Ohuchida M, Kakita N, and Morimatsu M: Immortalization of human aortic smooth muscle cells with origin-minus simian virus 40 DNA. Biotechnol Appl Biochem, 16: 152−160, 1992
(34) Sasaguri Y, Yanagi H, Nagase H, Nakano R, Fukuda S, and Morimatsu M: Collagenase production by immortalized human aortic endothelial cells infected with simian virus 40. Virchows Arch B Cell Pathol Incl Mol Pathol, : 91−97, 1991
(35) Satoh T, Sugama K, Matsuo A, Kato S, Ito S, Hatanaka M, and Sasaguri Y: Histamine as an activator of cell growth and extracellular matrix reconstruction for human vascular smooth muscle cells. Atherosclerosis, 110: 53−61, 1994
(36) Sasaguri Y and Tanimoto A: Extracellular matrix and matrix metalloproteinses in atherosclerosis. Connective Tissue, 34: 327−336, 2002
(37) Jeannin P, Delneste P, Gosset S, Molet P, Lassalle P, Hamid A, Tsicopoulos A, and Tonnel AB: Histamine induced interleukin-8 secretion by endothelial cells. Blood, 84, 2229−2233, 1994
(38) Delneste Y, Lassalle P, Jeannin P, Joseph M, Tonnel AB, and Gosset P: Histamine induces IL-6 production by human endothelial cells. Clin Exp Immunol, 98: 344−349, 1994
(39) Li Y, Chi L, Stechschulte DJ, and Dileepan KN: Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha. Microvasc Res, 61: 253−262, 2001
(40) Saito H, Shimizu H, Mita H, Maeda Y, and Akiyama K: Histamine augments VCAM-1 expression on IL-4- and TNF-alpha-stimulated human umbilical vein endothelial cells. Int Arch Allergy Immunol, 111: 126−132, 1996
(41) Miki I, Kusano A, Ohta S, Hanai N, Otoshi M, Masaki S, Sato S, and Ohmori K: Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells. Cell Immunol, 171: 285−288, 1996
(42) Li H, Burkhardt C, Heinrich UR, Brausch I, Xia N, and Forstermann U: Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation, 107: 2348−2354, 2003
(43) Schaefer U, Schmitz V, Schneider A, and Neugebauer E: Histamine induced homologous and heterologous regulation of histamine receptor subtype mRNA expression in cultured endothelial cells. Shock, 12: 309−315, 1999
(44) Schaefer U, Schneider A, Rudroff C, and Neugebauer E: Nitric oxide mediates histamine induced down-regulation of H2 receptor mRNA and internalization of the receptor protein (R1). Cell Mol Life Sci, 60: 1968−1981, 2003
(45) Wierzbicki T, Iqbal SM, Cuvelier SL, Awong G, Tibbles LA, and Patel KD: IL-4 primes human endothelial cells for secondary responses to histamine. J Leukoc Biol, 74: 420−427, 2003
(46) Igaz P, Novak I, Lazaar E, Horvath B, Heninger E, and Falus A: Bidirectional communication between histamine and cytokines. Inflamm Res, 50: 123−128, 2001
(47) Young JL, Libby P, and Schonbeck U: Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost, 88: 554−567, 2002
(48) Krishnaswamy G, Kelley J, Yerra L, Smith JK, and Chi DS: Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res, 19: 91−104, 1999
(49) Vannier E, Miller LC, and Dinarello CA: Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors. J Exp Med, 174: 281−284, 1991
(50) Bissonnette EY: Histamine inhibits tumor necrosis factor alpha release by mast cells through H2 and H3 receptors. Am J Respir Cell Mol Biol, 14: 620−626, 1996
(51) Kume N and Kita T: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis. Trends Cardiovasc Med, 11: 22−25, 2001
(52) Kimura S, Wang KY, Tanimoto A, Murata Y, Nakashima Y, and Sasaguri Y: Acute inflammatory reactions caused by histamine via monocytes/macrophages chronically participate in the initiation and progression of atherosclerosis - Effects of Histamine on MCP-1-. Pathol Int, 54: 465−475, 2004
(54) Hansson GK: Inflammation and immune response in atherosclerosis. Curr Atheroscler Rep, 2: 150−155, 1999
(55) Laurat E, Poirier B, Tupin E, Caligiuri G, Hansson GK, Bariety J, and Nicoletti A: In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation, 104: 197−202, 2001
(56) Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, Curtiss LK, Berliner JA, and Boisvert WA: Overexpression of interleukin-10 by activated T lymphocytes inhibit atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Cir Res, 90: 1064−1071, 2002
(57) Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, Gately MK, Warrier RR, Pham N, Fogelman AM, and Modlin RL: Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest, 97: 2130−2138, 1996
(58) Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, and Hansson GK: Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis, 145: 33−43, 1999
(59) Jutel M, Klunker S, Akdis M, Malolepszy J, Thomet OA, Zak-Nejmark T, Blaser K, and Akdis CA: Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression. Int Arch Allergy Immunol, 124: 190−192, 2001
(60) Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J, Zak-Nejmark T, Koga R, Kobayashi T, Blaser T, and Akdis CA: Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature, 413: 420−425, 2001
(61) Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, and Wilder RL: Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol, 161: 2586−2593, 1998
(62) Van der Pouw Kraan TC, Snijders A, Boeije LC, de Groot ER, and Alewijnse AE: Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest, 102: 1866−1873, 1998
(63) Mazzoni A, Young HA, Spitzer JH, Visintin A, and Segal DM: Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest, 108: 1865−1873, 2001
(64) Dohlsten M, Sjogren HO, and Carlsson R: Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-g production. Cell Immunol, 109: 65−74, 1987
(65) Packard KA and Khan MM: Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol, 3: 909−920, 2003
(66) Sirois J, Menard G, Moses AS, and Bissonnette EY: Importance of histamine in the cytokine network in the lung through H2 and H3 receptors: Stimulation of IL-10 production. J Immunol, 164: 2964−2970, 2000
(67) Plenz G, Koenig C, Severs NJ, and Robenek H: Smooth muscle cells express granulocyte-macrophage colony-stimulating factor in the undiseased and atherosclerotic human coronary artery. Arterioscler Thromb Vasc Biol, 17: 2489−2499, 1997
(68) Miyazawa N, Watanabe S, Matsuda A, Kondo K, Hashimoto H, Umemura K, and Nakashima M: Role of histamine H1 and H2 receptor antagonists in the prevention of intimal thickening. Eur J Pharmacol, 362: 53−59, 1998
(69) Ohtsu H, Tanaka S, Terui T, Hori Y, Makabe-Kobayashi Y, Pejler G, Tchougounova E, Hellman L, Gertsenstein M, Hirasawa N, Sakurai E, Buzas E, Kovacs P, Csaba G, Kittel A, Okada M, Hara M, Mar L, Numayama-Tsuruta K, Ishigaki-Suzuki S, Ohuchi K, Ichikawa A, Falus A, Watanabe T, and Nagy A: Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett, 502: 53−56, 2001
(70) Stoa-Birketvedt G, Paus PN, Ganss R, Ingebretsen OC, and Florholmen J: Cimetidine reduces weight and improves metabolic control in overweight patients with type 2 diabetes. Int JObes Relat Metab Disord, 22: 1041−1045, 1998
(71) Sacchetti E, Guarneri L, and Bravi D: H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients. Biol Psychiatry, 48: 167−168, 2000
(72) Birketvedt GS, Thom E, Bernersen B, and Florholmen J: Combination of diet, exercise and intermittent treatment of cimetidine on body weight and maintenance of weight loss. Med Sci Monit, 6: 699−703, 2000